On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.
![risperidone penalty](https://www.drugjustice.com/wp-content/uploads/2016/08/jj_to_pay_nearly_8_million_risperdal_settlement-840x440.jpg)
On Feb. 26, 2015, South Carolina’s Supreme Court ordered Johnson & Johnson to pay $136 million is Risperdal lawsuit penalties.
Risperdal, an antipsychotic developed by the Janssen brand of Johnson & Johnson, has long been approved by the Food and Drug Administration for schizophrenia.